Remote Precision Medicine Biomarker Lead – Oncology

Amgen Inc.; United States; Remote; USD 190,000 - 270,000; Full time

Benefits offered by this job

Competitive salary

Total Rewards Plan

Stock-based incentives

Flexible work models

Job summary

Amgen Inc. in the United States is seeking a Precision Medicine Global Biomarker Lead – Oncology Clinical Biomarkers to shape biomarker strategies across programs and drive translational insights.

You will partner with cross-functional teams to enable clinical decision-making and support regulatory submissions. The role emphasizes leadership in biomarker strategy, assay development, and external collaborations, with a focus on immuno-oncology and other oncology modalities.

Qualifications

• Doctorate degree with 3+ years in oncology biomarker work.
• Master’s with 5+ years in oncology biomarker work.
• Bachelor’s with 7+ years in oncology biomarker work.
• Associate’s with 12+ years in oncology biomarker work.
• High school diploma with 14+ years in oncology biomarker work.

Responsibilities

• Develop and drive clinical biomarker strategies for one or more programs.
• Create testable hypotheses for patient stratification and pharmacodynamics.
• Own biomarker elements in protocols and regulatory submissions.
• Build relationships with KOLs, academics, and external partners.
• Collaborate with cross-functional teams to drive biomarker innovation.
• Communicate key biomarker findings to leadership and teams.

Skills

Biomarker strategy

Oncology biomarkers

Clinical development

Cross-functional leadership

Biomarker assay development

External collaborations

Regulatory submissions

Education

PhD or MD

Master's degree

Bachelor's degree

Tools

Biomarker platforms

Assay development

Job description

Amgen Inc. in the United States is seeking a Precision Medicine Global Biomarker Lead – Oncology Clinical Biomarkers to shape biomarker strategies across programs and drive translational insights.

You will partner with cross-functional teams to enable clinical decision-making and support regulatory submissions. The role emphasizes leadership in biomarker strategy, assay development, and external collaborations, with a focus on immuno-oncology and other oncology modalities.